Robert F. Green

Robert F. Green

Attorney Profile

Top Rated Intellectual Property Litigation Attorney in Chicago, IL

Green, Griffith & Borg-Breen LLP
 | 676 N. Michigan Avenue, Suite 3900
Chicago, IL 60611
Phone: 312-883-8000
Fax: 312-883-8001
Selected to Super Lawyers: 2009 - 2019
Licensed Since: 1974
Practice Areas:
  • Intellectual Property Litigation (70%),
  • Intellectual Property (30%)
Attorney Profile

Robert F. Green is a founding partner of Green, Griffith & Borg-Breen LLP. He practices IP law exclusively, with a concentration in pharmaceutical, biochemical and chemical litigation and opinions.

Mr. Green has represented clients under the Hatch- Waxman Act since it was passed in 1984.  As lead counsel in Hatch-Waxman litigation, he has litigated patents covering over 40 drug products, serving both plaintiffs and defendants. Mr. Green has argued over a dozen pharmaceutical patent appeals before the Federal Circuit Court of Appeals. He has broad experience managing patent portfolios, counselling and rendering opinions on patent validity and infringement. He also specializes in formulating patent strategies in the pharmaceutical field for both brand and generic pharmaceutical companies.

Since founding Green Griffith, Mr. Green successfully defended Dexcel against alleged infringement of Takeda’s Orange Book-listed patents for lansoprazole delayed-released orally disintegrating tablets (“ODT”).  As a result of this ruling, Dexcel launched the first lansoprazole ODT product sold Over-The-Counter (“OTC”) in the US market.

In addition, Mr. Green has been instrumental in obtaining favorable settlements for Horizon Pharma in litigations related to Abbreviated New Drug Applications filed by various generic drug companies. Mr. Green also was counsel for Cipla in litigation relating to Cipla's ANDA that sought approval to market a generic equivalent to Helsinn's Aloxi® palonosetron product. That litigation settled with a favorable generic product entry date.

Mr. Green previously was Vice President of Leydig, Voit & Mayer, the inside Patent Counsel for Celanese Chemical Company, and the inside counsel for the U.S. chemical division IP counsel for Akzona (now AkzoNobel). Mr. Green’s successes include many from which his clients were awarded market exclusivity, including the products Zantac®, OTC omeprazole tablets, Plendil®, and Platinol®.

About Robert Green

Admitted: 1974, Illinois

Professional Webpage: http://greengriffith.com/robert-green/

Honors/Awards:

  • Listed in The Best Lawyers in America in Litigation – Intellectual Property Law, 2016 ‐ 2019
  • Recognized by Illinois Super Lawyers list in Intellectual Property Litigation, 2009 ‐ 2018
  • Recognized as a “Global IP Star” by Managing IP, 2018
  • Selected as a “Life Sciences Star” in LMG Life Sciences, 2012 ‐ 2018
  • Listed in Intellectual Asset Management’s (IAM) Patent 1000 in Litigation, 2015 - 2018
  • Named as one of “The World’s Leading Patent Practitioners” in Intellectual Asset Management’s (IAM) 1000, 2012
  • Recognized as one of “The World’s Leading Patent Litigators” in Intellectual Asset Management’s IAM Patent Litigation 250, 2011
  • Named as one of “The World’s Leading Life Sciences Patent Litigators” in Intellectual Asset Management’s IAM Life Sciences 250, 2010
  • Selected by peers as a Leading Lawyer in Intellectual Property Law and Patent Law, 2004 - 2019, Advisory Board Member, 2016 - 2019 – Leading Lawyers Network

Special Licenses/Certifications:

  • Registered Patent Attorney, U.S. Patent and Trademark Office, No. 27,555
  • U.S. District Court for the Northern District of Illinois
  • U.S. Court of Appeals for the District of Columbia
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Supreme Court
  • State of Illinois Supreme Court

Scholarly Lectures/Writings:

  • “The US Pharmaceutical Industry-Driving Forces-Patent And FDA,” speaker for first round panel presentation, AIPPI Israel 2018: 3rd International Convention on The Economy of Innovation, Tel Aviv, Israel, 2018
  • Moderated IP track “The Impact of KSR, Seagate, Quanta, and Bilski on Business Decisions,” Inside Counsel SuperConference, Chicago, IL, 2009
  • “Non‐Patent Exclusivity,” presented at the FDA Boot Camp‐Chicago Edition, Chicago, IL, 2006, 2007
  • “Innovation and its Discontents,” presented at the John Marshall Law School, Chicago, IL, 2005
  • “Shared Exclusivity Past, Present and Future,” presented at the Generic Pharmaceutical Association (GPhA), Legal Symposium, Boca Raton, FL, 2004

Educational Background:

  • The John Marshall Law School, J.D., 1974
  • University of Illinois, B.S. in Chemistry, 1971

Industry Groups

  • Chemical
  • Pharmaceutical
Office Location for Robert F. Green

676 N. Michigan Avenue
Suite 3900
Chicago, IL 60611

Robert F. Green:

Last Updated: 10/18/2018

Page Generated: 0.47257590293884 sec